Criteria | Inclusion | Exclusion |
---|---|---|
Population | Humans | Animals/Plants |
All ages/sexes | Â | |
Individuals in FCASa | Â | |
Refugees or migrants in LMICa | Â | |
Intervention/Exposure | Infections/colonization with an antibiotic resistant organism (Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacteriaceae (Escherichia coli and/or Klebsiella pneumonia), and/or Staphylococcus aureus) | Tuberculosis |
Comparator | Susceptible infections/colonization or absence of infection/colonization | Â |
Outcomes | Associated health burden (mortality, morbidity …) | Molecular biology only |
All economic perspectives | Â | |
Associated healthcare cost burden, direct costs (resource use, opportunity cost …) | Epidemiology only | |
Indirect costs (loss of productivity …) |  | |
Intangible costs (decreased quality of life …) |  | |
Study design | Case-control studies | Conference abstracts |
Cohort studies | Posters | |
Cross-sectional studies | Systematic reviews | |
Randomised controlled studies | Â | |
Modelling studies | Â | |
Economic evaluations | Â |